Miguel-Angel Perales
0000-0002-5910-4571
38 papers found
Refreshing results…
Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease
Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States
Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant
Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome
Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation
The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial
Racial disparities in access to alternative donor allografts persist in the era of “donors for all”
Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma
Missing publications? Search for publications with a matching author name.